UPDATE : Tuesday, November 20, 2018
HOME Pharma
Vetter wins Corporate Health Award
  • By Marian Chu
  • Published 2017.12.07 10:55
  • Updated 2017.12.07 10:55
  • comments 0

Global contract development and manufacturing organization Vetter Pharma has won the Corporate Health Award for excellent management and promotion of employees’ health, it said Wednesday.

“The company offers all employees the opportunity to do something positive for themselves and incorporates their overall health,” Vetter’s Managing Director Peter Soelkner said. “In doing so, we also highlight those factors we consider to be the most important to our company’s success story, namely, the employees.”

Vetter’s Senior Vice President of Human Resources, Markus Maiwald (second from left) and Petra Hagel, head of Vetter’s Occupational Health Management hold the certificate of Corporate Health Award, during a recent ceremony.

The Corporate Health Award, now in its ninth year, annually recognizes companies that made a significant contribution to the healthcare of their employees while pursuing a sustainable human resource strategy, Vetter said.

The companies are judged on categories such as health-promoting services, innovative processes, and the interlocking of the program with the individual executive level, it added.

“We find that Vetter has a well-planned and highly structured concept in place,” said Markus A.W. Hoehner, EuPD Research CEO and Corporate Health Award initiator. “The entire program is holistic in design and therefore offers the employees real added value,”

Vetter said it invests a six-figure sum for its health management services.

“As a company that operates in the healthcare sector, it is a matter of course for us to apply this essence of quality across the board, including those actions concerning the healthcare services we offer our employees. The well-being and good health of all the staff are important in this respect,” Soelkner said.

Vetter is best known for developing, manufacturing and packaging injectable drugs for clients, including the world’s top 20 pharma and biotech companies.


<© Korea Biomedical Review, All rights reserved.>

Other articles by Marian Chu
iconMost viewed
Comments 0
Please leave the first comment.
Back to Top